JTK-101 is a selective inhibitor of HIV-1, primarily targeting Tat cofactors such as CDK9 and cyclin T1. By inhibiting these cofactors, JTK-101 effectively reduces HIV-1 mRNA synthesis and suppresses the transcriptional activity of the virus. This compound is valuable for research applications focused on anti-HIV therapeutic strategies and understanding HIV transcription regulation.
JTK-101 is a selective inhibitor of HIV-1, primarily targeting Tat cofactors such as CDK9 and cyclin T1. By inhibiting these cofactors, JTK-101 effectively reduces HIV-1 mRNA synthesis and suppresses the transcriptional activity of the virus. This compound is valuable for research applications focused on anti-HIV therapeutic strategies and understanding HIV transcription regulation.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
